Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamideShannon R. McCurdy, Yvette L. Kasamon, Javier Bolaños‐Meade et al.|Blood|2015Cited by 299
Comparison of Outcomes of HLA-Matched Related, Unrelated, or HLA-Haploidentical Related Hematopoietic Cell Transplantation following Nonmyeloablative Conditioning for Relapsed or Refractory Hodgkin LymphomaLauri M. Burroughs, David G. Maloney, Paul V. O’Donnell et al.|Biology of Blood and Marrow Transplantation|2008Cited by 264
Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamideShannon R. McCurdy, Leo Luznik, Yvette L. Kasamon et al.|Haematologica|2016Cited by 187
The European Society for Blood and Marrow Transplantation (EBMT) consensus recommendations for donor selection in haploidentical hematopoietic cell transplantationStefan O. Ciurea, Arnon Nagler, Rupert Handgretinger et al.|Bone Marrow Transplantation|2019Cited by 161
Effect of increased dose of total body irradiation on graft failure associated with HLA-haploidentical transplantation in patients with severe haemoglobinopathies: a prospective clinical trialJavier Bolaños‐Meade, Robert A. Brodsky, Kenneth R. Cooke et al.|The Lancet Haematology|2019Cited by 154